TY - JOUR
T1 - A case of dysferlinopathy asymptomatic for 10 years after an episode of transient muscle weakness
AU - Kobayashi, Yoshito
AU - Takahashi, Toshiaki
AU - Sumi, Hisae
AU - Fujimura, Harutoshi
AU - Aoki, Masashi
AU - Takahashi, Masanori P.
AU - Sakoda, Saburo
PY - 2012/7
Y1 - 2012/7
N2 - We report a 28-year-old male with dysferlinopathy, who has remained asymptomatic for 10 years from a rhabdomyolysis-like episode. He had been in good health since birth, but felt difficulty in walking after a month and a half of manual labor at 18 years old (at the year 2000). Rhabdomyolysis was suspected because of muscle weakness and elevated serum CK of 28,094 U/L. He was hospitalized and his muscle weakness improved. He was referred to us, because his serum CK remained around 2,000 U/L. Histological analysis of muscle, when antidysferlin antibody was unavailable, was not informative but later analysis at the age of 23 using preserved specimen showed loss of dysferlin immunoreactivity. Subsequently, a missense mutation (c.2997G>T) and a deletion (c.3373delG) of the dysferlin gene, both of which are common in Miyoshi myopathy in Japanese, were identified. He continuously showed hyper-CKemia, but no apparent muscle weakness emerged for more than ten years. Reports on asymptomatic dysferlinopathy over such a long duration are rare. This case may suggest that genetic factors, environmental factors such as intensity of work-load, or both, might affect the clinical course of dysferlinopathy. Further follow-up is necessary.
AB - We report a 28-year-old male with dysferlinopathy, who has remained asymptomatic for 10 years from a rhabdomyolysis-like episode. He had been in good health since birth, but felt difficulty in walking after a month and a half of manual labor at 18 years old (at the year 2000). Rhabdomyolysis was suspected because of muscle weakness and elevated serum CK of 28,094 U/L. He was hospitalized and his muscle weakness improved. He was referred to us, because his serum CK remained around 2,000 U/L. Histological analysis of muscle, when antidysferlin antibody was unavailable, was not informative but later analysis at the age of 23 using preserved specimen showed loss of dysferlin immunoreactivity. Subsequently, a missense mutation (c.2997G>T) and a deletion (c.3373delG) of the dysferlin gene, both of which are common in Miyoshi myopathy in Japanese, were identified. He continuously showed hyper-CKemia, but no apparent muscle weakness emerged for more than ten years. Reports on asymptomatic dysferlinopathy over such a long duration are rare. This case may suggest that genetic factors, environmental factors such as intensity of work-load, or both, might affect the clinical course of dysferlinopathy. Further follow-up is necessary.
KW - Asymptomatic hyperCKemia
KW - Dysferlin
KW - Limb girdle muscular dystrophy
KW - Miyoshi myopathy
UR - http://www.scopus.com/inward/record.url?scp=84864447095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864447095&partnerID=8YFLogxK
U2 - 10.5692/clinicalneurol.52.495
DO - 10.5692/clinicalneurol.52.495
M3 - Article
C2 - 22849992
AN - SCOPUS:84864447095
SN - 0009-918X
VL - 52
SP - 495
EP - 498
JO - Clinical Neurology
JF - Clinical Neurology
IS - 7
ER -